Tsai MH, Chen YY, Liou HH, Wang JT, et al. Febuxostat leads to better cardiovascular outcomes compared to allopurinol in patients with advanced chronic kidney disease: A Population-based Cohort Study. Am J Med 2024 Sep 26:S0002-9343(24)00622-3. doi: 10.1016/j.amjmed.2024.
PMID: 39341524